US Patent 7371380 Anti-Cark antibodies and uses therefor

Patent 7371380 was granted and assigned to Millennium Pharmaceuticals on May, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Millennium Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7371380

Date of Patent

May 13, 2008

Patent Application Number

11186283

Date Filed

July 21, 2005

Patent Primary Examiner

‌

Michail Belyavskyi

Patent abstract

The invention provides isolated nucleic acids molecules, designated CARK nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing CARK nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a CARK gene has been introduced or disrupted. The invention still further provides isolated CARK proteins, fusion proteins, antigenic peptides and anti-CARK antibodies. Diagnostic methods utilizing compositions of the invention are also provided.